Long‐Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer
Top Cited Papers
Open Access
- 5 May 2017
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 6 (5), e005633
- https://doi.org/10.1161/jaha.117.005633
Abstract
Background Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of heart disease is uncertain. We performed a meta‐analysis to investigate the link between radiotherapy and long‐term cardiovascular morbidity and mortality in patients with breast cancer. Methods and Results We performed a literature search using MEDLINE (January 1966 to January 2015) and EMBASE (January 1980 to January 2015) with no restrictions. Studies that reported relative risk ( RR ) estimates with 95% CI s for the associations of interest were included. Pooled effect estimates were obtained by using random‐effects meta‐analysis. Thirty‐nine studies involving 1 191 371 participants were identified. Patients who received left‐sided radiotherapy, as compared with those receiving right‐sided radiotherapy, experienced increased risks of developing coronary heart disease ( RR 1.29, 95% CI 1.13‐1.48), cardiac death ( RR 1.22, 95% CI 1.08‐1.37) and death from any cause ( RR 1.05, 95% CI 1.01‐1.10). In a comparison of patients with radiotherapy and without radiotherapy, the RR s were 1.30 (95% CI 1.13‐1.49) for coronary heart disease and 1.38 (95% CI 1.18‐1.62) for cardiac mortality. Radiotherapy for breast cancer was associated with an absolute risk increase of 76.4 (95% CI 36.8‐130.5) cases of coronary heart disease and 125.5 (95% CI 98.8‐157.9) cases of cardiac death per 100 000 person‐years. The risk started to increase within the first decade for coronary heart disease and from the second decade for cardiac mortality. Conclusions Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent risk of coronary heart disease and cardiac mortality.This publication has 68 references indexed in Scilit:
- B-Type Natriuretic Peptide and Prognosis of End-Stage Renal Disease: A Meta-AnalysisPLOS ONE, 2013
- Long-term Cardiac Mortality After Hypofractionated Radiation Therapy in Breast CancerInternational Journal of Radiation Oncology*Biology*Physics, 2013
- Current and Former Smoking and Risk for Venous Thromboembolism: A Systematic Review and Meta-AnalysisPLoS Medicine, 2013
- Cardiac Morbidity and Mortality in Women with Ductal Carcinoma In Situ of the Breast Treated with Breast Conservation TherapyThe Breast Journal, 2011
- The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: A single-institution studyEuropean Journal of Cancer, 2011
- Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831Journal of Clinical Oncology, 2009
- Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early‐stage breast cancerCancer, 2007
- Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation TreatmentJournal of Clinical Oncology, 2006
- Risk of Cardiac Death After Adjuvant Radiotherapy for Breast CancerJNCI Journal of the National Cancer Institute, 2005
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002